Multiple forms of human P450 expressed in Saccharomyces cerevisiae

Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians

Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., & Guengerich, F. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22379-5 · Cited by 2,785

Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism.

Guengerich, F. P., Martin, M. V., Beaune, P. H., Kremers, P. G., Wolff, T., & Waxman, D. J. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89213-x · Cited by 724

Characterization of the common genetic defect in humans deficient in debrisoquine metabolism

Gonzalez, F. J., Skodat, R. C., Kimura, S., Umeno, M., Zanger, U. M., Nebert, D. W., Gelboin, H. V., Hardwick, J. P., & Meyer, U. (1988) · Nature · doi:10.1038/331442a0 · Cited by 715

Separation and characterization of highly purified forms of liver microsomal cytochrome P-450 from rats treated with polychlorinated biphenyls, phenobarbital, and 3-methylcholanthrene.

Ryan, D. E., Thomas, P. E., Korzeniowski, D., & Levin, W. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34211-4 · Cited by 567

Complementary DNA and protein sequences of ethanol-inducible rat and human cytochrome P-450s. Transcriptional and post-transcriptional regulation of the rat enzyme.

Song, B., Gelboin, H. V., Park, S. S., Yang, C. S., & Gonzalez, F. J. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)66620-7 · Cited by 405

The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene.

Kimura, S., Umeno, M., Skoda, R. C., Meyer, U., & Gonzalez, F. J. (1989) · Europe PMC (PubMed Central) · Cited by 404

The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes

Yamano, S., Tatsuno, J., & Gonzalez, F. J. (1990) · Biochemistry · doi:10.1021/bi00457a031 · Cited by 384

Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism.

Distlerath, L. M., Reilly, P. E. B., Martin, M. V., Davis, G., Wilkinson, G. R., & Guengerich, F. P. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39456-5 · Cited by 319

Isolation, complementary DNA sequence, and regulation of rat hepatic lauric acid omega-hydroxylase (cytochrome P-450LA omega). Identification of a new cytochrome P-450 gene family.

Hardwick, J. P., Song, B. J., Huberman, E., & Gonzalez, F. J. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75857-8 · Cited by 312

Characterization of three highly purified cytochromes P-450 from hepatic microsomes of adult male rats.

Ryan, D. E., Iida, S., Wood, A. W., Thomas, P. E., Lieber, C. S., & Levin, W. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43594-0 · Cited by 297

Metabolic Extraction of Nifedipine during Absorption from the Rat Small Intestine

Iwao, T., Inoue, K., Hayashi, Y., Yuasa, H., & Watanabe, J. (2002) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.17.546 · Cited by 28

Species differences in metabolism of ripasudil (K-115) are attributed to aldehyde oxidase

Isobe, T., Ohta, M., Kaneko, Y., & Kawai, H. (2015) · Xenobiotica · doi:10.3109/00498254.2015.1096981 · Cited by 27

The regiospecific hydroxylation of lauric acid by rainbow trout (Oncorhynchus mykiss) cytochrome P450s.

Buhler, D. R., Miranda, C. L., Deinzer, M. L., Griffin, D. A., & Henderson, M. C. (1997) · PubMed · Cited by 26

Reversible binding of ethacrynic acid to human serum albumin: Difference circular dichroism study

Bertucci, C., Nanni, B., & Salvadori, P. A. (1999) · Chirality · doi:10.1002/(sici)1520-636x(1999)11:1 · Cited by 24

Spectrofluorometric Analysis of CYP2A6-Catalyzed Coumarin 7-Hydroxylation

Waxman, D. J., & Chang, T. K. H. (2003) · Humana Press eBooks · doi:10.1385/0-89603-519-0:111 · Cited by 24

Mediation of Arachidonic Acid Metabolite(s) Produced by Endothelial Cytochrome P-450 3A4 in Monkey Arterial Relaxation.

Ayajiki, K., Fujioka, H., Toda, N., Okada, S., Minamiyama, Y., Imaoka, S., Funae, Y., Watanabe, S., Nakamura, A., & Okamura, T. (2003) · Hypertension Research · doi:10.1291/hypres.26.237 · Cited by 24

Biotransformation of methyl tert-butyl ether by human cytochrome P450 2A6

Shamsipur, M., Beigi, A. A. M., Teymouri, M., Poursaberi, T., Mostafavi, S. M., Soleimani, P., Chitsazian, F., & Tash, S. A. (2011) · Biodegradation · doi:10.1007/s10532-011-9510-0 · Cited by 23

Development of Two-dimensional Template System for the Prediction of CYP2B6-mediated Reaction Sites

Koyama, N., & Yamazoe, Y. (2011) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-10-rg-097 · Cited by 23

Effect of selected antidepressant drugs on cytochrome P450 2B (CYP2B) in rat liver. An in vitro and in vivo study.

Haduch, A., Wójcikowski, J., & Daniel, W. A. (2008) · PubMed · Cited by 22

Quantitation of Human Cytochrome P450 2D6 Protein with Immunoblot and Mass Spectrometry Analysis

Yu, A., Qu, J., Felmlee, M. A., Cao, J., & Jiang, X.-L. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.024166 · Cited by 22

Comparison of Steroid Hormone Hydroxylations by and Docking to Human Cytochromes P450 3A4 and 3A5

Niwa, T., Narita, K., Okamoto, A., Murayama, N., & Yamazaki, H. (2019) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/jpps30558 · Cited by 21

Genotoxicity and Mutagenicity - Mechanisms and Test Methods

Soloneski, S., & Larramendy, M. L. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.84992 · Cited by 22

Establishment of a yeast system that stably expresses human cytochrome P450 reductase: Application for the study of drug metabolism of cytochrome P450s in vitro

Cheng, J., Wan, D., Gu, J., Gong, Y., Yang, S., Hao, D., & Yang, L. (2005) · Protein Expression and Purification · doi:10.1016/j.pep.2005.11.022 · Cited by 21

Inhibitory effect of synthetic cannabinoids on CYP1A activity in mouse liver microsomes

Ashino, T., Hakukawa, K., Itoh, Y., & Numazawa, S. (2014) · The Journal of Toxicological Sciences · doi:10.2131/jts.39.815 · Cited by 18

Demethylation of neferine in human liver microsomes and formation of quinone methide metabolites mediated by CYP3A4 accentuates its cytotoxicity

Shen, Q., Zuo, M., Ma, L., Tian, Y. E., Wang, L., Jiang, H., Zhou, Q., Zhou, H., Yu, L., & Zeng, S. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.10.014 · Cited by 18

Dietary-Induced Obesity, Hepatic Cytochrome P450, and Lidocaine Metabolism: Comparative Effects of High-Fat Diets in Mice and Rats and Reversibility of Effects With Normalization of Diet

Nebaihi, H. M. S. A., Batran, R. A., Ussher, J. R., Maayah, Z. H., El‐Kadi, A. O. S., & Brocks, D. R. (2019) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.11.007 · Cited by 18

In Vitro Characterization of the Cytochrome P450 Isoforms Involved in the Metabolism of 6-Methoxy-2-napthylacetic Acid, an Active Metabolite of the Prodrug Nabumetone

Matsumoto, K., Nemoto, E., Hasegawa, T., Akimoto, M., & Sugibayashi, K. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.734 · Cited by 17

Quantitative reverse transcriptase/PCR assay for the measurement of induction in cultured hepatocytes

Mattes, W. B., & Li, A. P. (1997) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(97)00073-2 · Cited by 17

Disparity in Holoprotein/Apoprotein Ratios of Different Standards Used for Immunoquantification of Hepatic Cytochrome P450 Enzymes

Perrett, H. F., Barter, Z. E., Jones, B. C., Yamazaki, H., Tucker, G., & Rostami‐Hodjegan, A. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.015743 · Cited by 17

Amino Acid Residues Affecting the Activities of Human Cytochrome P450 2C9 and 2C19

Niwa, T., Kageyama, A., Kishimoto, K., Yabusaki, Y., Ishibashi, F., & Katagiri, M. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.8.931 · Cited by 16

Cloning and Characterization of the CYP2D1-Binding Protein, Retinol Dehydrogenase

Imaoka, S., Wan, J., Chow, T., Hiroi, T., Eyanagi, R., Shigematsu, H., & Funae, Y. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0644 · Cited by 16

Heterologous Expression of Recombinant Human Cytochrome P450 (CYP) in Escherichia coli: N-Terminal Modification, Expression, Isolation, Purification, and Reconstitution

Shang, T., Fang, C.-M., Ong, C. E., & Pan, Y. (2023) · BioTech · doi:10.3390/biotech12010017 · Cited by 15

Involvement of pregnane X receptor in the regulation of CYP2B6 gene expression by oltipraz in human hepatocytes

Piton, A., Rauch, C., Langouët, S., Guillouzo, A., & Morel, F. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.09.025 · Cited by 15

The Effect of Genetic Polymorphism on the Inhibition of Azole Antifungal Agents Against CYP2C9-Mediated Metabolism

Niwa, T., & Hata, T. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.01.007 · Cited by 15

Effect of genetic polymorphism on the inhibition of dopamine formation from p -tyramine catalyzed by brain cytochrome P450 2D6

Niwa, T., Shizuku, M., & Yamano, K. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.03.009 · Cited by 15

Sex differences in pharmacokinetics of cilostazol in rats

Kamada, N., Yamada, K., Odomi, M., Mukai, T., Nishibayashi, T., Ogawara, K., Kimura, T., & Higaki, K. (2011) · Xenobiotica · doi:10.3109/00498254.2011.590242 · Cited by 15

Species difference in the inhibition of pentobarbital metabolism by empenthrin

Tsuji, R., Isobe, N., Kurita, Y., Hanai, K., Yabusaki, Y., & Kawasaki, H. (1996) · Environmental Toxicology and Pharmacology · doi:10.1016/s1382-6689(96)00066-x · Cited by 15

Cytochrome P450 2B6 Amperometric Biosensor for Continuous Monitoring of Propofol

Ferrier, D. C., Kiely, J., & Luxton, R. W. (2021) · IEEE Sensors Journal · doi:10.1109/jsen.2021.3112273 · Cited by 15

Inhibition of Human Hepatic Cytochrome P450s and Steroidogenic CYP17 by Nonylphenol.

Niwa, T., Maekawa, Y., Fujimoto, M., Kishimoto, K., Yabusaki, Y., Ishibashi, F., & Katagiri, M. (2002) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.25.235 · Cited by 15

Transcriptomic analysis across liver diseases reveals disease-modulating activation of constitutive androstane receptor in cholestasis

Mathur, B., Arif, W., Patton, M. E., Faiyaz, R., Liu, J., Yeh, J., Harpavat, S., Schoonjans, K., Kalsotra, A., Wheatley, A. M., et al. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100140 · Cited by 14

14,15‐epoxyeicosatrienoic acid produced by cytochrome P450s enhances neurite outgrowth of PC 12 and rat hippocampal neuronal cells

Oguro, A., Inoue, T., Kudoh, S. N., & Imaoka, S. (2018) · Pharmacology Research & Perspectives · doi:10.1002/prp2.428 · Cited by 14

Cytochrome P450 is Responsible for Nitric Oxide Generation from NO-Aspirin and Other Organic Nitrates

Minamiyama, Y., Takemura, S., Imaoka, S., Funae, Y., & Okada, S. (2007) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.22.15 · Cited by 14

Effect of short- and long-term treatment with antidepressant drugs on the activity of rat CYP2A in the liver.

Haduch, A., Wójcikowski, J., & Daniel, W. A. (2005) · PubMed · Cited by 14

Specific binding of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl propyl) piperazine (GBR-12935), an inhibitor of the dopamine transporter, to human CYP2D6

Hiroi, T., Imaoka, S., Chow, T., Yabusaki, Y., & Funae, Y. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00172-x · Cited by 14

Comparative 1-Substituted Imidazole Inhibition of Cytochrome P450 Isozyme-Selective Activities in Human and Mouse Hepatic Microsomes

Franklin, M. R., & Constance, J. E. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530701498570 · Cited by 14

Xenobiotic-metabolizing cytochrome P450 enzymes in human lung

Hukkanen, J. (2000) · Cited by 14

Effect of Chronic Kidney Disease on Hepatic Clearance of Drugs in Rats

Tokunaga, A., Miyamoto, H., Fumoto, S., & Nishida, K. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b20-00124 · Cited by 13

The activity of cytochrome P450 CYP2B in rat liver during neuroleptic treatment.

Haduch, A., Wójcikowski, J., & Daniel, W. A. (2007) · PubMed · Cited by 13

Anti-CYP2D6 antibodies detected by quantitative radioligand assay and relation to antibodies to liver-specific arginase in patients with autoimmune hepatitis

Kimura, M., Tatsumi, K., Tada, H., Izumi, Y., Kaneko, A., Kato, M., Masuzawa, M., Ikemoto, M., Yabusaki, Y., Hidaka, Y., et al. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00747-1 · Cited by 13

Pronamide: Weight of evidence for potential estrogen, androgen or thyroid effects

Marty, M. S., Papineni, S., Coady, K. K., Rasoulpour, R. J., Pottenger, L. H., & Eisenbrandt, D. L. (2015) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2015.03.016 · Cited by 12

Evaluation of hypothermia on thein vitrometabolism and binding andin vivodisposition of midazolam in rats

Miyamoto, H., Matsueda, S., Moritsuka, A., Shimokawa, K., Hirata, H., Nakashima, M., Sasaki, H., Fumoto, S., & Nishida, K. (2015) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1960 · Cited by 12

Efavirenz biotransformation as an up-stream event of mood changes in HIV-infected patients

Grilo, N. M., Correia, M. J., Sequeira, C. O., Harjivan, S. G., Caixas, U., Diogo, L. N., Marques, M. M., Monteiro, E. C., Antunes, A. M. M., & Pereira, S. A. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.08.009 · Cited by 12

The Inhibitory Effect of Telmisartan on the Metabolism of Arachidonic Acid by CYP2C9 and CYP2C8: An in Vitro Study

Kato, Y., Mukai, Y., Rane, A., Inotsume, N., & Toda, T. (2017) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b17-00174 · Cited by 12

Applications of Heterologous Expressed and Purified Human Drug-Metabolizing Enzymes

Rodrigues, A. D. (1999) · CRC Press eBooks · doi:10.1201/b13995-13 · Cited by 12

Induction of olfactory mucosal and liver metabolism of lidocaine by 2,3,7,8‐tetrachlorodibenzo‐p‐dioxin

Genter, M. B., Apparaju, S., & Desai, P. B. (2002) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.10032 · Cited by 11

A Mechanism-Based Integrated Pharmacokinetic Enzyme Model Describing the Time Course and Magnitude of Phenobarbital-Mediated Enzyme Induction in the Rat

Magnusson, M. O., Karlsson, M. O., & Sandström, R. (2006) · Pharmaceutical Research · doi:10.1007/s11095-005-9571-z · Cited by 10

Telomere sequences at the novel joints of four independent amplifications in Saccharomyces cerevisiae

Moore, I. K., Martin, M. P., & Paquin, C. E. (2000) · Environmental and Molecular Mutagenesis · doi:10.1002/1098-2280(2000)36:2 · Cited by 6

Characterization of lidocaine metabolism by rat nasal microsomes: implications for nasal drug delivery

Deshpande, V. S., Genter, M. B., Jung, C., & Desai, P. B. (1999) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03190366 · Cited by 10

A New Epitope of CYP2D6 Recognized by Liver Kidney Microsomal Autoantibody from Japanese Patients with Autoimmune Hepatitis

Imaoka, S., Obata, N., Hiroi, T., Osada‐Oka, M., Hara, R., Nishiguchi, S., & Funae, Y. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.2240 · Cited by 10

Metabolism and interactions of pesticides in human and animal in vitro hepatic models

Abass, K. M. (2010) · Cited by 10

Cytochrome P450 4A11 inhibition assays based on characterization of lauric acid metabolites

Choi, Y. J., Zhou, Y., Lee, J.-Y., Ryu, C. S., Kim, Y. H., Lee, K., & Kim, S. K. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.12.063 · Cited by 9

Determination of CYP2B6 Component of 7-Ethoxy-4-Trifluoromethylcoumarin O-Deethylation Activity in Human Liver Microsomes

Chang, T. K. H., Crespi, C. L., & Waxman, D. J. (2006) · Humana Press eBooks · doi:10.1385/1-59259-998-2:97 · Cited by 9

Roles of Residues F206 and V367 in Human CYP2B6: Effects of Mutations on Androgen Hydroxylation, Mechanism-Based Inactivation, and Reversible Inhibition

Lin, H.-L., Zhang, H., Kenaan, C., & Hollenberg, P. F. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.071662 · Cited by 8

Inhibitory and Stimulatory Effects of Selective Serotonin Reuptake Inhibitors on Cytochrome P450 2D6-mediated Dopamine Formation from p-Tyramine

Niwa, T., & Sugimoto, S. (2019) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/jpps30622 · Cited by 7

Metal oxide decorated carbon nanocomposite electrodes for propofol monitoring

Ferrier, D. C., Kiely, J., & Luxton, R. W. (2022) · Biosensors and Bioelectronics X · doi:10.1016/j.biosx.2022.100286 · Cited by 7

POLIMORFISMOS DE CITOCROMO P450: PAPEL COMO MARCADOR BIOLÓGICO

Santiago, C., & Gómez‐Gallego, F. (2002) · Cited by 7

CYP 450 Enzymes in Drug Discovery and Development: An Overview

Xu, L. S., Das, B., & Prakash, C. (2012) · Encyclopedia of Drug Metabolism and Interactions · doi:10.1002/9780470921920.edm117 · Cited by 7

Metabolism of non-steroidal anti-inflammatory drugs (NSAIDs) by Streptomyces griseolus CYP105A1 and its variants

Yogo, Y., Yasuda, K., Takita, T., Yasukawa, K., Iwai, Y., Nishikawa, M., Sugimoto, H., Ikushiro, S., & Sakaki, T. (2022) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2022.100455 · Cited by 6

Relative contribution of rat CYP isoforms responsible for stereoselective metabolism of carvedilol

Iwaki, M., Niwa, T., Nakamura, Y., Kawase, A., & Komura, H. (2018) · The Journal of Toxicological Sciences · doi:10.2131/jts.43.59 · Cited by 6

Abundance and Associated Variations of Cytochrome P450 Drug-Metabolizing Enzymes in the Liver of East Asian Adults: A Meta-Analysis

An, X., Yu, Y., Li, G., & Yu, G. (2020) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-020-00667-9 · Cited by 6

Comparison of the Stimulatory and Inhibitory Effects of Steroid Hormones and α-Naphthoflavone on Steroid Hormone Hydroxylation Catalyzed by Human Cytochrome P450 3A Subfamilies

Niwa, T., Toyota, M., Kawasaki, H., Ishii, R., & Sasaki, S. (2021) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b20-00987 · Cited by 6

Evaluation of the Ecstasy influence on tramadol and its main metabolite plasma concentration in rats

Jamali, B., Sheikholeslami, B., Ardakani, Y. H., Lavasani, H., & Rouini, M. R. (2017) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmpt-2017-0018 · Cited by 6

Non-coplanar 2,2′,3,3′,4,4′,5,5′,6,6′-decachlorobiphenyl (PCB 209) did not induce cytochrome P450 enzyme activities in primary cultured rat hepatocytes, was not genotoxic, and did not exhibit endocrine-modulating activities

Han, X., O’Connor, J. C., Donner, E. M., Nabb, D. L., Mingoia, R. T., Snajdr, S. I., Clarke, J. J., & Kaplan, A. M. (2008) · Toxicology · doi:10.1016/j.tox.2008.10.013 · Cited by 6

Efficient sex hormone biosensors in Saccharomyces cerevisiae cells to evaluate human aromatase activity and inhibition

Wu, J., Bureik, M., & Marchisio, M. A. (2025) · Scientific Reports · doi:10.1038/s41598-024-85022-7 · Cited by 5

Impact of steroid hormone levels on estradiol‐mediated regulation of cytochrome P450 2B6 compared to 1B1 in breast cancer cells

Hoffmann, M., Müller, J. P., Maurer, J., Folliot, A., Yamoune, S., & Stingl, J. (2024) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.14069 · Cited by 5

Whole Cell-Dependent Biosynthesis of Drug Metabolites Using Genetically Engineered Budding Yeast

Ikushiro, S., Nishikawa, M., & Sakaki, T. (2014) · Springer eBooks · doi:10.1007/978-4-431-54992-5_10 · Cited by 4

Quality Related Safety Evaluation of a South African Traditional Formulation (PHELA®) as Novel Anti-Biofilm Candidate

Das, B., Kar, A., Bhowmik, R., Karmakar, S., Tripathy, S., Matsabisa, M. G., & Mukherjee, P. K. (2022) · Molecules · doi:10.3390/molecules27041219 · Cited by 4

Regioselective Versatility of Monooxygenase Reactions Catalyzed by CYP2B6 and CYP3A4: Examples with Single Substrates

Erratico, C., Deo, A. K., & Bandiera, S. M. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-16009-2_5 · Cited by 4

The role of cytochrome P450 pharmacogenomics in chronic non-cancer pain patients

Tverdohleb, T., Dinç, B., Knezevic, I., Candido, K. D., & Knežević, N. N. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2016.1209482 · Cited by 4

Awareness and acceptance of hepatitis B vaccination in Clementi, Singapore.

Fong, N. P., Basir, H., & Seow, A. (1990) · PubMed · Cited by 4

Drug-Metabolizing Enzymes

Chang, T. K. H. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-362-6_4 · Cited by 4

Stimulatory and Inhibitory Effects of Steroid Hormones and Human Cytochrome P450 (CYP) 3A Inhibitors on Cortisol 6β-Hydroxylation Catalyzed by CYP3A Subfamilies

Niwa, T., Tani, M., Suzuki, A., & Murakami, M. (2023) · Drug Metabolism and Bioanalysis Letters · doi:10.2174/2949681016666230830125358 · Cited by 3

Comprehensive Review of CYP2B6 Transcriptional Modulators, Variants, and Their Role in Drug Interactions

Hatta, M. N. M. M., & Latip, N. A. (2025) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/3162 · Cited by 3

Effect of Human Cytochrome P450 2D6 Polymorphism on Progesterone Hydroxylation

Niwa, T., Sasaki, S., Yamamoto, Y., & Tanaka, M. (2022) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-022-00784-7 · Cited by 3

Species difference of drug metabolism: difficulty of prediction of drug disposition in human from animal data

Imai, T. (2007) · Drug Delivery System · doi:10.2745/dds.22.48 · Cited by 3

Points-to-consider documents: Scientific information on the evaluation of genetic polymorphisms during non-clinical studies and phase I clinical trials in the Japanese population

Hiratsuka, M., Hirasawa, N., Oshima, Y., Kodama, S., Miyata, T., Dan, T., Takatoku, H., Kuribayashi, H., Nakamura, R., & Saito, Y. (2018) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2018.01.005 · Cited by 3

Role of amino acids at positions 34, 296, and 486 of cytochrome P450 2D6 in the stimulatory and inhibitory effects of psychotropic agents on dopamine formation from p-tyramine

Niwa, T., Arima, J., & Michihiro, Y. (2021) · Xenobiotica · doi:10.1080/00498254.2021.1989520 · Cited by 3

Chapter 12 Cytochrome p450 (cyp) and udp-glucuronosyltransferase (ugt) enzymes: role in drug metabolism, polymorphism, and identification of their involvement in drug metabolism

Ghosal, A., Ramanathan, R., Kishnani, N. S., Chowdhury, S. K., & Alton, K. B. (2005) · Progress in pharmaceutical and biomedical analysis · doi:10.1016/s1464-3456(05)80014-6 · Cited by 2

Epitope Mapping of Rat Cytochrome P450 2B1 Using Glutathione S-Transferase-2B1 Fusion Constructs

Parimoo, B., & Thomas, P. E. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.1922 · Cited by 2

Interspecies comparison of hepatic metabolism of six newly synthesized retinoid X receptor agonistic compounds possessing a 6-[N-ethyl-N-(alkoxyisopropylphenyl)amino]nicotinic acid skeleton in rat and human liver microsomes

Murakami, Y., Shimizu, Y., Ogasawara, A., Ueshima, S., Nakayama, M., Kawata, K., Kakuta, H., & Aiba, T. (2013) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2013.807278 · Cited by 2

Immunohistochemical approach to obesity disease in terms of expression levels of glutathione s-transferase (sigma, zeta, theta) isozymes

DAVUDOV, M., Buluş, H., Di̇ri̇can, O., Kaygın, P., Şımşek, G., Sarıaltın, S. Y., GÜRBÜZ, F. N., & Oğuztüzün, S. (2023) · The European Research Journal · doi:10.18621/eurj.1121110 · Cited by 2

MOLECULAR GENETIC ANALYSIS OF HUMAN IMMUNODEFICIENCY VIRUS ANTIRETROVIRAL THERAPY RESPONSE IN SOUTH AFRICA - A PHARMACOGENETICS STUDY

Parathyras, J. B. (2007) · SUNScholar (Stellenbosch University) · Cited by 2

An Investigation of CYP2B in Rat Brain: Regulation and Role in Drug and Toxin Response

Khokhar, J. Y. (2012) · TSpace (University of Toronto) · Cited by 2

Pharmacodynamics of enzyme induction and its consequences for substrate elimination.

Magnusson, M. O. (2007) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 2

Safety Evaluation of Fucoidan from Kjellmaniella Crassiforia and Extract from Hypsizigus Marmoreus: Influence on the Activities and Gene Expressions of Rat Hepatic CYPs

Ohnogi, H., Kudo, Y., Hayami, S., Takimoto, Y., SUZUKI, R., & Suzuki, N. (2012) · Japanese Journal of Complementary and Alternative Medicine · doi:10.1625/jcam.9.1 · Cited by 1

Genotoxic Assays for Measuring P450 Activation of Chemical Mutagens

Fasullo, M. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.90356 · Cited by 1

Influence of High-fat and High-cholesterol Diet on Major CYP Activities in the Liver

Suzuki, S., Sato, Y., Umegaki, K., & Chiba, T. (2016) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.16-00034 · Cited by 1

HISTORY OF DRUG METABOLISM RESEARCH IN JAPAN*

Kato, R., & Yamazoe, Y. (2000) · Drug Metabolism Reviews · doi:10.1081/dmr-100100563 · Cited by 1

Overview of major CYP450 isoforms and "Cocktail Approach"

Bai, X.-B., & Liu, C. (2005) · Cited by 1

ACTIVATION OF ESTROGEN RECEPTOR ALPHA, ARYL HYDROCARBON RECEPTOR, AND NUCLEAR FACTOR ERYTHROID-2 LIKE 2 IN HUMAN BREAST CANCER CELLS

Lo, R. (2014) · TSpace (University of Toronto) · Cited by 1

Alternative Androgen Metabolism in Resistance to Aromatase Inhibitors.

Sikora, M. J. (2011) · Deep Blue (University of Michigan)

Drug-Metabolizing Enzymes and P-Glycoprotein

Chang, T. K. H. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-781-9_3

Do Cytochrome P450 Enzymes Contribute to the Metabolism of Xenobiotics in Human?

Abass, K. M., Reponen, P., Turpeinen, M., Mattila, S., & Pelkone, O. (2010) · InTech eBooks · doi:10.5772/13730

Purification of Cytochrome P‐450 Enzymes

Bell, L. C., Hosea, N. A., Martin, M. V., & Guengerich, F. P. (1999) · Current Protocols in Toxicology · doi:10.1002/0471140856.tx0402s12

Automatable microplate-based in vitro assays for screening intestinal drug transport and metabolism

Soikkeli, A. (2012) · Työväentutkimus Vuosikirja

HEPATIC DRUG METABOLISM

Huang, W., Lin, Y. S., McConn, D. J., Calamia, J. C., Totah, R. A., Isoherranen, N., Glodowski, M., & Thummel, K. E. (2004)

Effect of Bakumondo-to on cytochrome P450 activities in rat liver microsomes

Yasuhara, M., Tayama, Y., Kashiwagi, T., Sawa, A., Kihira, K., & Miyake, K. (2016) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2016.02.003

Mrp4 Is a Crucial Regulator of Testosterone Biosynthesis

Morgan, J. (2012) · doi:10.21007/etd.cghs.2012.0217

Detection of Cytochrome P450 Induction. Development of Non-Invasive Assay.

Imaoka, S., & Funae, Y. (2000) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.15.46

The Effect of Altering Brain CYP2B Activity on Nicotine Self-administration Behaviour and Nicotine Levels in the Brain

Garcia, K. L. P. (2016) · TSpace (University of Toronto)

PURIFICATION AND CHARACTERIZATION OF YEAST-EXPRESSED HUMAN P450S AND COMPARISON OF THEM WITH PURIFIED RAT P450S

Imaoka, S., Yamada, T., Hiroi, T., Hayashi, K., Sakaki, T., Yabusaki, Y., & Funae, Y. (1994) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.9.supplement_140

Characterization of three cytochrome P450s purified from renal microsomes of untreated male rats and comparison with human renal cytochrome P450

Imaoka, S., Nagashima, K., & Funae, Y. (1990) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(90)90747-m · Cited by 53

Localization of rat Cytochrome P450 in Various Tissues and Comparison of Arachidonic Acid Metabolism by Rat P450 with that by Human P450 Orthologs

Imaoka, S., Hashizume, T., & Funae, Y. (2005) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.20.478 · Cited by 83

Roles of Human Cytochrome P450 Enzymes Involved in Drug Metabolism and Toxicological Studies

Yamazaki, H. (2000) · YAKUGAKU ZASSHI · doi:10.1248/yakushi1947.120.12_1347 · Cited by 6

Purification of Human Liver Cytochrome P-450 Catalyzing Testosterone 6β-Hydroxylation1

KAWANO, S., Kamataki, T., Yasumori, T., Yamazoe, Y., & Kato, R. (1987) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a122081 · Cited by 52